|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-04-28 Sale |
2008-04-28 8:59 pm | CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 5,000 | $16.23 | $81,147 | 15,000 (Direct) | View |
| 2008-04-21 Sale |
2008-04-23 6:46 pm | CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 5,000 | $16.05 | $80,252 | 20,000 (Direct) |
View |
| 2008-04-14 Sale |
2008-04-16 8:01 pm |
CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 5,000 | $17.03 | $85,168 | 25,000 (Direct) |
View |
| 2008-04-07- -2008-04-08 Sale |
2008-04-09 9:10 pm | CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 5,000 | $18.31 | $91,565 | 30,000 (Direct) |
View |
| 2008-03-31 Sale | 2008-04-01 7:56 pm |
CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 2,125 | $17.94 | $38,129 | 35,000 (Direct) | View |
| 2008-03-28- -2008-03-31 Sale | 2008-04-01 7:29 pm | CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 7,875 | $17.6 | $138,612 | 37,125 (Direct) |
View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price | Total Amount |
Shares Ownership | Filing |
| 2008-05-02 Option Award | 2008-05-06 7:44 pm | CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 10,000 | $0 | $0 | 25,000 (Direct) | View |
| 2005-05-02 Option Award | 2005-05-04 5:13 pm | CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 45,000 | $0 | $0 | 45,000 (Direct) |
View |
| 2005-02-28 Exercise | 2005-03-02 6:58 pm | ANDRX CORP | ADRX | MOVENS DANIEL H (President of Anda, Inc.) | 8,000 | $8.34 | $66,720 | 30,361 (Direct) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Ownership |
Filing |
| 2007-08-09 Option Award |
2007-08-10 10:26 am |
N/A 2013-08-09 |
CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 40,000 | $13.82 | 40,000 (Direct) |
View |
| 2006-07-11 Option Award |
2006-07-19 10:59 am |
N/A 2012-07-11 | CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 40,000 | $9.03 | 40,000 (Direct) |
View |
| 2006-07-11 Option Award | 2006-07-18 7:37 pm | N/A 2012-07-11 | CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 40,000 | $9.03 | 40,000 (Direct) |
View |
| 2005-05-02 Option Award |
2005-05-04 5:13 pm | N/A 2011-05-02 |
CARACO PHARMACEUTICAL LABORATORIES LTD | CPD | MOVENS DANIEL H (Chief Executive Officer Director) | 40,000 | $8.31 | 40,000 (Direct) | View |
| 2005-02-28 Exercise |
2005-03-02 6:58 pm | N/A 2005-03-02 |
ANDRX CORP | ADRX | MOVENS DANIEL H (President of Anda, Inc.) | 8,000 | $8.34 | 0 (Direct) | View |
| 2004-01-27 Option Award | 2004-01-28 7:04 pm |
N/A 2014-01-27 |
ANDRX CORP | ADRX | MOVENS DANIEL H (EVP, Operations of Anda, Inc.) | 40,000 | $25.64 | 40,000 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Tue, 02 Dec 2008 15:21:03 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |